Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0045|75|8|798-805
ISSN: 0270-4137
Source: THE PROSTATE, Vol.75, Iss.8, 2015-06, pp. : 798-805
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Safety and efficacy of 2‐weekly cabazitaxel in metastatic castration‐resistant prostate cancer
BJU INTERNATIONAL, Vol. 121, Iss. 2, 2018-02 ,pp. :
MiR200c targets IRS1 and suppresses prostate cancer cell growth
THE PROSTATE, Vol. 75, Iss. 8, 2015-06 ,pp. :
Methylselenocysteine preventing castration‐resistant progression of prostate cancer
THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. :
Role of Immunotherapy in Castration‐Resistant Prostate Cancer (CRPC)
BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. :